Related Experiment Video
Updated: Jun 3, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
In vitro sensitivity of human metapneumovirus to type I interferons
Carolina Scagnolari1, Simona Trombetti, Carla Selvaggi
1Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome, Rome, Italy.
Abstract:
Human metapneumovirus (hMPV) has been recognized as an important respiratory pathogen. Due to its relatively recent discovery, only limited information is available on the relationship between hMPV and type I interferons (IFN). This study was designed to determine whether in vitro hMPV is sensitive to the antiviral activity of IFN-β, leukocyte IFN-α, and several IFN-α subtypes in a human Hep-2 cell line. The results showed that 50% inhibitory concentration values against hMPV for the various type I IFN preparations were significantly higher than those against the IFN-sensitive vesicular stomatitis virus, and some IFN-α subtypes appeared to be more active against hMPV than others, with IFN-α subtypes 5, 6, 8, and 10 being the most potent, and IFN-α2, 17, and 21 the least potent. The results show that hMPV grown in Hep-2 is partially resistant to the antiviral activity of type I IFNs. Additional studies are required to understand whether and to what extent the relatively low sensitivity of hMPV to IFNs influences the clinical outcomes of infected individuals.
Insights
Human metapneumovirus (hMPV) shows partial resistance to type I interferons (IFN). This suggests a need for further research into how hMPV
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human metapneumovirus (hMPV) is a significant respiratory pathogen.
- Limited data exists on the interaction between hMPV and type I interferons (IFN).
Purpose of the Study:
- To investigate the in vitro sensitivity of hMPV to type I interferons (IFN-β, IFN-α subtypes).
- To compare the antiviral activity of IFNs against hMPV and a known IFN-sensitive virus.
Main Methods:
- Utilized a human Hep-2 cell line for in vitro experiments.
- Determined 50% inhibitory concentration (IC50) values for various type I IFN preparations against hMPV.
- Compared IC50 values with those obtained for vesicular stomatitis virus (VSV).
Main Results:
- hMPV exhibited significantly higher IC50 values compared to VSV, indicating partial resistance to type I IFNs.
- Varied potency among IFN-α subtypes was observed, with subtypes 5, 6, 8, and 10 being most effective, and 2, 17, and 21 least effective.
- Overall, hMPV demonstrated partial resistance to the antiviral effects of type I IFNs in Hep-2 cells.
Conclusions:
- hMPV displays partial resistance to the antiviral activity of type I interferons in vitro.
- Further investigation is needed to determine the clinical implications of hMPV's reduced IFN sensitivity.
- Understanding this relationship may offer insights into hMPV pathogenesis and treatment strategies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

